Pharmacoepidemiology of testosterone prescribing in Australia, 1992–2010

Peter M Herriot
Med J Aust 2012; 197 (6): . || doi: 10.5694/mja12.11032
Published online: 17 September 2012

To the Editor: The recent article by Handelsman describes the pattern of testosterone prescribing in Australia from January 1992 to December 2010.1 The author concludes that the progressive increase in Pharmaceutical Benefits Scheme (PBS)-subsidised testosterone prescribing is likely to be due to promotion-driven prescribing for speculative, non-approved indications.1

  • Peter M Herriot

  • Pain Management Unit, Royal Adelaide Hospital, Adelaide, SA.


Competing interests:

No relevant disclosures.


remove_circle_outline Delete Author
add_circle_outline Add Author

Do you have any competing interests to declare? *

I/we agree to assign copyright to the Medical Journal of Australia and agree to the Conditions of publication *
I/we agree to the Terms of use of the Medical Journal of Australia *
Email me when people comment on this article

Online responses are no longer available. Please refer to our instructions for authors page for more information.